AstraZeneca PLC
1459.00
27-December-24 11:29:41
15 minutes delayed
Stocks
+5.00
+0.34%
Today's range
1445.00 - 1459.50
ISIN
N/A
Source
NASD.OMX SE
-
AZN : Imfinzi Combination Reduces Risk Of Disease Progression Or Death By 45% In Endometrial Cancer
21 Oct 2023 11:33:24 By NASDAQ US Markets
-
AstraZeneca: 59% Of Patients Treated With Tagrisso + Chemotherapy Had Complete Brain Tumor Responses
21 Oct 2023 11:33:23 By NASDAQ US Markets
-
AstraZeneca: TAGRISSO Plus Chemotherapy Granted Priority Review By FDA
16 Oct 2023 07:36:08 By NASDAQ US Markets
-
Ascentage, AstraZeneca Collaborate On Phase III Study Of Lisaftoclax Combination In CLL/SLL
15 Oct 2023 23:53:04 By NASDAQ US Markets
-
AstraZeneca Settles Lawsuits Alleging Heartburn Drugs Caused Kidney Disease For $425 Million
03 Oct 2023 09:12:46 By Forbes - World
-
AstraZeneca Settles Nexium, Prilosec Product Liability Litigations; To Pay $425 Mln
03 Oct 2023 03:04:52 By NASDAQ US Markets
-
29 Sep 2023 10:53:27 By MarketWatch
-
AstraZeneca PLC (AZN) Is a Trending Stock: Facts to Know Before Betting on It
26 Sep 2023 10:10:15 By NASDAQ Stocks
-
AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happening
26 Sep 2023 08:07:47 By Forbes - Markets
-
AstraZeneca Looks To China For Growth - But CEO Says Spinoff Not Happening
26 Sep 2023 08:02:57 By Forbes - World